Health Evaluation of Mushrooms withVitamin D2

Taipei Medical University

Status: Completed

Conditions: Healthy

Treatments: Dietary Supplement: Pleurotus citrinopileatus after bio-optics (10 ug group); Dietary Supplement: Pleurotus citrinopileatus after bio-optics (100 ug group)

Study type: Interventional

Funder types: Other

Identifiers

NCT05716698

N202111054

Details and patient eligibility

About

Although Taiwan has plenty of sunshine, the intake of vitamin D and the concentration of 25(OH)D in the blood are low. Ingestion of mushrooms and extracts rich in D2 can increase the nutritional source of vitamin D. The purpose of this study is to evaluate the intake of D2 mushrooms and extracts in humans to achieve the effective concentration of 25(OH)D in the serum and recommendations for health improvement.

Full description

The subjects were divided into 3 groups: no mushroom intervention, intervention with D2 10ug Pleurotus citrinopileatus after bio-optics optimization (low dose group) or intervention with D2 100ug Pleurotus citrinopileatus after bio-optics optimization (high dose group). The low-dose group took D2 10ug per day, and the high-dose group received D2 100ug per day for a total of 4 weeks.

Enrollment: 36 patients

Sex: All

Ages: 20 to 60 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

1. Healthy human

Exclusion criteria

1. Any acute disease, such as infection, stroke, myocardial infarction or major surgery within three months, upper or lower gastrointestinal bleeding, blood pressure, and poor blood sugar control will be excluded.
2. Chronic diseases, such as malignant tumors, infection with human immunodeficiency virus (HIV) and related diseases, liver cirrhosis, or those with liver function exceeding 3 times the normal value (more than 120 IU/L), renal function (Cr) more than 2.5 mg /dl, chronic anemia (Hb <9 g/dl), metabolic diseases except diabetes (such as thyroid/parathyroid dysfunction), and those who have undergone abdominal surgery to cause intestinal sticking are excluded.
3. Women who are pregnant or breastfeeding will be excluded.
4. Those who use steroids, supplements with vitamin D-containing dietary supplements and hormones will be excluded.
5. Those with blood 25(OH)D concentration > 30 ng/ml will be excluded.
6. Those who are unwilling to fill out the consent form and refuse the questionnaire survey.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

36 participants in 3 patient groups

Control Group

No Intervention group

Description:

no Pleurotus citrinopileatus intervention

D2 10ug Pleurotus citrinopileatus Group

Experimental group

Description:

took D2 10ug Pleurotus citrinopileatus per day for a total of 4 weeks.

Treatment:

Dietary Supplement: Pleurotus citrinopileatus after bio-optics (10 ug group)

D2 100ug Pleurotus citrinopileatus Group

Experimental group

Description:

took D2 100ug Pleurotus citrinopileatus per day for a total of 4 weeks.

Treatment:

Dietary Supplement: Pleurotus citrinopileatus after bio-optics (100 ug group)